Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD

ClinicalTrials.gov ID: NCT02766608

Public ClinicalTrials.gov record NCT02766608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 1:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort® Turbuhaler®, as an Active Control, on Lung Function Over a 24-Week Treatment Period in Subjects With Moderate to Very Severe COPD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase III randomized, double-blind, parallel group, multi-center, 24-week lung function study with BFF MDI (320/9.6 μg and 160/9.6 μg) compared to FF MDI 9.6 μg, BD MDI 320 μg, and open-label Symbicort® TBH (200/6 μg) administered BID.

Study identification

NCT ID
NCT02766608
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pearl Therapeutics, Inc.
Industry
Enrollment
2,389 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2016 (Actual)
Primary completion
Dec 1, 2017 (Actual)
Completion
Dec 1, 2017 (Actual)
Last update posted
Sep 24, 2019

2016 – 2017

United States locations

U.S. sites
83
U.S. states
27
U.S. cities
73
Facility City State ZIP Site status
Research Site Athens Alabama 35611 —
Research Site Birmingham Alabama 35243 —
Research Site Dothan Alabama 36305 —
Research Site Phoenix Arizona 85006 —
Research Site Phoenix Arizona 85020 —
Research Site Tucson Arizona 85745 —
Research Site Anaheim California 92801 —
Research Site Gold River California 95670 —
Research Site Palm Springs California 92262 —
Research Site Sacramento California 95823 —
Research Site San Diego California 92120 —
Research Site Boulder Colorado 80301 —
Research Site Colorado Springs Colorado 80907 —
Research Site Littleton Colorado 80127 —
Research Site Hamden Connecticut 06517 —
Research Site Clearwater Florida 33756 —
Research Site Clearwater Florida 33765 —
Research Site DeLand Florida 32720 —
Research Site Hialeah Florida 33016 —
Research Site Miami Florida 33134 —
Research Site Miami Florida 33175 —
Research Site Miami Florida 33186 —
Research Site Panama City Florida 32405 —
Research Site Port Orange Florida 32127 —
Research Site Port Orange Florida 32129 —
Research Site Tampa Florida 33603 —
Research Site Winter Park Florida 32789-4681 —
Research Site Blue Ridge Georgia 30513 —
Research Site Meridian Idaho 83646 —
Research Site Towson Maryland 21204 —
Research Site Westminster Maryland 21157 —
Research Site North Dartmouth Massachusetts 02747 —
Research Site Farmington Hills Michigan 48336 —
Research Site Edina Minnesota 55435 —
Research Site Fridley Minnesota 55432 —
Research Site Minneapolis Minnesota 55407 —
Research Site Woodbury Minnesota 55125 —
Research Site Saint Charles Missouri 63301 —
Research Site St Louis Missouri 63141 —
Research Site Henderson Nevada 89014 —
Research Site Henderson Nevada 89052 —
Research Site Las Vegas Nevada 89118 —
Research Site Jackson Heights New York 11236 —
Research Site Larchmont New York 10803 —
Research Site Charlotte North Carolina 28207 —
Research Site Gastonia North Carolina 28054 —
Research Site Greensboro North Carolina 27408 —
Research Site Huntersville North Carolina 28078 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Fargo North Dakota 58103 —
Research Site Columbus Ohio 43213 —
Research Site Columbus Ohio 43215 —
Research Site Dayton Ohio 45459 —
Research Site Dublin Ohio 43016 —
Research Site Grove City Ohio 43123 —
Research Site Oklahoma City Oklahoma 73103 —
Research Site Medford Oregon 97504 —
Research Site Pittsburgh Pennsylvania 15236 —
Research Site Pittsburgh Pennsylvania 15243 —
Research Site Anderson South Carolina 29621 —
Research Site Easley South Carolina 29640 —
Research Site Gaffney South Carolina 29341 —
Research Site Greenville South Carolina 29615 —
Research Site Mt. Pleasant South Carolina 29464 —
Research Site Old Point Station South Carolina 29707 —
Research Site Rock Hill South Carolina 29732 —
Research Site Seneca South Carolina 29678 —
Research Site Spartanburg South Carolina 29303 —
Research Site Union South Carolina 29379 —
Research Site Johnson City Tennessee 37601 —
Research Site Kingsport Tennessee 37660 —
Research Site Channelview Texas 77530 —
Research Site Live Oak Texas 78233 —
Research Site New Braunfels Texas 78130 —
Research Site San Antonio Texas 78212 —
Research Site San Antonio Texas 78229 —
Research Site Sugar Land Texas 77479 —
Research Site South Burlington Vermont 05403 —
Research Site Newport News Virginia 23606 —
Research Site Richmond Virginia 23294 —
Research Site Bellevue Washington 98004 —
Research Site Bellevue Washington 98007 —
Research Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 176 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02766608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2019 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02766608 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →